Seres Therapeutics

Nov 05, 2025

•

Sep 30, 2025

Seres Therapeutics Q3 2025 Earnings Report

Estimated Revenue:$5.88M

-80.7% YoY

Estimated EPS:$0.76

+411.8% YoY

Seres Therapeutics

Unlock previous datapoints

Upgrade

Seres Therapeutics

Unlock previous datapoints

Upgrade

Loading...

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Seres Therapeutics

Key Statistics

Market Cap

$135M

P/E Ratio

-19.14

Sector

N/A

Industry

N/A

52-Week High

$28.6

52-Week Low

$6.74

Products

Get in Touch

Resources

Seres Therapeutics

Seres Therapeutics Q3 2025 Earnings Report

Seres Therapeutics

Seres Therapeutics

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Key Statistics